1 Dividend King Stock Down 25% to Buy Right Now

S&P Global shares have fallen 17% year to date and 25% from their 52-week high as investors worry generative AI could pressure data providers and after 2026 EPS guidance of $19.40-$19.65 missed the $19.96 consensus. The stock now trades at 27.4x earnings and 22x forward earnings, its cheapest valuation since late 2022. Offsetting those concerns, the company still holds about 50% credit ratings market share, a 52% first-quarter operating margin, and has raised its dividend for 53 straight years.

Analysis

The market is treating SPGI as if AI is a direct substitute for trust, which is the wrong abstraction. AI can compress basic data gathering, but it does not eliminate the legal, reputational, and process frictions that make regulated ratings and institutional datasets sticky; if anything, it raises the bar for auditability and provenance. The more plausible second-order effect is margin defense: AI should lower cost-to-serve and speed product iteration, so the earnings multiple compression may be over-penalizing a business that can use the same technology to widen operating leverage.

The bigger near-term issue is not existential disruption but guidance credibility. When a high-quality compounder misses the forward number, the stock often de-rates for 1-2 quarters until management proves that the slowdown is cyclical rather than structural. That creates a setup where the tape can remain weak despite stable fundamentals, especially if credit issuance or market activity softens and investors extrapolate a slower reset in the ratings and intelligence franchises.

Relative value still looks favorable versus MCO if the market is pricing both as if AI risk were symmetric; SPGI arguably has more optionality from workflow automation and the planned separation. The spin should also act as a catalyst for multiple clarity, since a cleaner financial-information pure play may attract a different buyer base and improve sum-of-parts optics. The key contrarian point: the selloff may be less about AI disruption and more about the market finally applying a lower growth multiple to a business that has been priced as quasi-defensive growth.

The risk is that investor patience runs out before the catalyst arrives. If management cannot re-accelerate guidance within the next 1-2 earnings cycles, the stock can stay range-bound even if AI fears prove overstated. That makes this more of a 6-12 month reset story than a quick mean-reversion trade.

Key Decisions for Investors

• Initiate a starter long in SPGI over the next 1-2 weeks, targeting a 12-month hold; use the current de-rating as entry, with upside from multiple re-rating if execution stabilizes and the spin improves sum-of-parts visibility.
• Pair trade: long SPGI / short MCO for 3-6 months; SPGI has more visible AI-enabled margin leverage and a clearer near-term catalyst, while the valuation gap can narrow if ratings softness is already embedded.
• Buy SPGI Jan-2027 call spreads on further weakness; this expresses a recovery over a 12-18 month horizon with defined downside, suitable if the market is still overpricing AI substitution risk.
• Avoid chasing the bounce until the next guidance reset; if the company fails to narrow the 2026 EPS gap over the next earnings cycle, add only after confirmation rather than on narrative relief.
• Monitor post-spin positioning: if the mobility separation creates indiscriminate selling, add to SPGI on technical dislocation, as forced flow could offer a better entry than pre-event anticipation.